ImmunityBio, Inc. IBRX Reportable Segment — Other expense, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s reportable segment — other expense, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s reportable segment — other expense, net?
- ImmunityBio, Inc. (IBRX) reported reportable segment — other expense, net of -$5.92M in Q1 2026.
- How has ImmunityBio, Inc.'s reportable segment — other expense, net changed year-over-year?
- ImmunityBio, Inc.'s reportable segment — other expense, net decreased by 14331.7% year-over-year, from -$41K to -$5.92M.
- What does reportable segment — other expense, net mean?
- Captures miscellaneous non-operating expenses and income items that do not fit into primary operating or interest categories. This includes items like foreign exchange gains/losses, asset disposals, or other non-recurring charges.